Novel parameter based on lipid indicators ratio improves prognostic value of plasma lipid levels in resectable colorectal cancer patients

doi:10.4240/wjgs.v13.i7.689

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5138)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

241

WORD

124

HTML

2412

Figures (1-2)

267

Tables (1-5)

361

Sum=3405

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

483

Download

1250

Sum=1733

Jul 27, 2021 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Jul 27, 2021; 13(7): 689-701
Published online Jul 27, 2021. doi: 10.4240/wjgs.v13.i7.689

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier curves for progression-free survival and overall survival of colorectal cancer patients according to two hallmarks consisting of the ratio of lipid biomarkers (high-density lipoprotein cholesterol/low-density lipoprotein cholesterol ratio and apolipoprotein A1/apolipoprotein B ratio). A: Kaplan-Meier curves for progression-free survival (PFS) of colorectal cancer patients according to high-density lipoprotein cholesterol/low-density lipoprotein cholesterol (HDL-C/LDL-C) ratio; B: Kaplan-Meier curves for overall survival (OS) of colorectal cancer patients according to HDL-C/LDL-C ratio; C: Kaplan-Meier curves for PFS of colorectal cancer patients according to ApoA1/ApoB ratio; and D: The Kaplan-Meier curves for OS of colorectal cancer patients according to ApoA1/ApoB ratio.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan-Meier curves for progression-free survival and overall survival of colorectal cancer patients according to lipoprotein cholesterol-apolipoprotein score. A: Kaplan-Meier curves for progression-free survival of colorectal cancer patients according to lipoprotein cholesterol-apolipoprotein (LA) score; B: Kaplan-Meier curves for overall survival of colorectal cancer patients according to LA score.

Citation: Gu JN, Yao S, Cao YH, Deng SH, Mao FW, Jiang HY, He YT, Li XY, Ke SQ, Li HL, Li H, Liu XH, Liu HL, Wang JL, Wu K, Liu L, Cai KL. Novel parameter based on lipid indicators ratio improves prognostic value of plasma lipid levels in resectable colorectal cancer patients. World J Gastrointest Surg 2021; 13(7): 689-701
URL: https://www.wjgnet.com/1948-9366/full/v13/i7/689.htm
DOI: https://dx.doi.org/10.4240/wjgs.v13.i7.689